It is time to rethink the dual antiplatelet therapy indication in revascularization surgery

被引：0
|
作者：
Bono, Julio O. E. [1 ,2 ]
Bratti, Juan P. Ricarte [1 ]
机构：
[1] Sanat Allende Nueva Cordoba, Cordoba, Argentina
[2] Direcc Postal Ituzaingo 755 PB B, RA-5000 Cordoba, Argentina
来源：
REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA | 2023年 / 52卷 / 01期
关键词：
Coronary artery bypass grafting; dual antiplatelet therapy; saphenous vein graft failure; ARTERY-BYPASS-SURGERY; PATENCY; YEAR; GRAFT PATENCY; TICAGRELOR; ASPIRIN; METAANALYSIS; PREVENTION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Dual antiplatelet therapy (DAP) in coronary artery bypass grafting (CABG) surgery in the context of stable ischemic heart disease is in increasing development, although ACC/AHA and European guidelines do not strongly recommend it and have different criteria. Saphenous vein graft failure in the first month in the postoperative period of surgery is not only frequent but serious. The balance between thrombotic and hemorrhagic risk must be obtained in these pa-tients with the objective of identifying those who will benefit with DAP and those who will not. In this opinion paper the newest evidence is shown for considering DAP for the postoperative period in CABG.
引用
收藏
页码：5 / 7
页数：3
相关论文
共 50 条
  • [1] Platelet function testing to time surgery in patients on dual antiplatelet therapy?
    Mahla, E.
    Raggam, R.
    Toller, W.
    HAMOSTASEOLOGIE, 2014, 34 (01): : 40 - 45
  • [2] Major Bleeding after Surgical Revascularization with Dual Antiplatelet Therapy
    Schlachtenberger, Georg
    Deppe, Antje Christin
    Gerfer, Stephen
    Choi, Yeong-Hoon
    Zeriouh, Mohamed
    Liakopoulos, Oliver
    Wahlers, Thorsten C. W.
    THORACIC AND CARDIOVASCULAR SURGEON, 2020, 68 (08): : 714 - 722
  • [3] Alternatives to Dual Antiplatelet Therapy Are Not Recommended After Transcarotid Revascularization
    Dakour-Aridi, Hanaa
    Motaganahalli, Raghu L.
    Fajardo, Andres
    Harlin, Stuart
    Tanaka, Akiko
    Keyhani, Arash
    Keyhani, Kourosh
    Wang, S. Keisin
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (06) : E276 - E277
  • [4] Predictors of secondary revascularization after coronary artery bypass graft surgery and role of dual antiplatelet therapy
    Iftikhar Ali Ch
    Khurram Nasir
    Azhar Chaudhry
    Pei-Tzu Wu
    Muhammad Siddique
    Raja Ullah
    Mashal Tahirkheli
    Abdul Qadar
    Hunter Weitzel
    Rahat Jamal
    Naeem Tahirkheli
    Journal of Cardiothoracic Surgery, 20 (1)
  • [5] LEFT ATRIAL APPENDAGE CLOSURE VERSUS TRIPLE ANTITHROMBOTIC THERAPY IN PATIENTS WITH LONG TIME INDICATION TO DUAL ANTIPLATELET THERAPY
    Vella, C.
    Festorazzi, C.
    Ancona, M.
    Bellini, B.
    Ferri, L.
    Russo, F.
    Ghizzoni, G.
    Gentile, D.
    Montorfano, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [6] Dual-antiplatelet therapy after endovascular revascularization of infrainguinal arteries
    Giannopoulos, Stefanos
    Armstrong, Ehrin J.
    VASCULAR MEDICINE, 2019, 24 (06) : 536 - 538
  • [7] A Brief History of the Proper Time for Antiplatelet Therapy in Peripheral Revascularization
    Vlachopoulos, Charalambos
    Terentes-Printzios, Dimitrios
    Aboyans, Victor
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (23) : 2371 - 2374
  • [8] Major Abdominal Surgery With Continued Dual Antiplatelet Therapy
    Quante, Markus
    Benckert, Christoph
    Thelen, Armin
    Kaisers, Udo
    Jonas, Sven
    ARCHIVES OF SURGERY, 2011, 146 (11) : 1334 - 1335
  • [9] Dual Antiplatelet Therapy in Peripheral Arterial Disease and After Peripheral Percutaneous Revascularization
    Hanna, Elias B.
    JOURNAL OF INVASIVE CARDIOLOGY, 2012, 24 (12): : 679 - 684
  • [10] Dual antiplatelet therapy in patients with acute coronary syndrome treated by surgical revascularization
    Parenica, Jiri
    Nemec, Petr
    COR ET VASA, 2014, 56 (03) : E246 - E253
12345